Resumo

HEVIA-URRUTIA, Francisco Javier. Adefovir Dipivoxil. Acta méd. costarric [online]. 2008, vol.50, suppl.3, pp.51-52. ISSN 0001-6002.

Adefovir is a nucleotide orally administrated with unknown resistance until two years of treatment. It is recommended for patients with chronic hepatitis B + and e -, it is resistant to Lamivudine. It is a well tolerated drug by decompensated, transplanted cirrhotic. Dose adjustment is required in renal impairment.

Palavras-chave : treatment; ADF; adefovir.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )